Genscript Biotech (OTCMKTS:GNNSF) Shares Down 0.4% – Should You Sell?

Shares of Genscript Biotech Co. (OTCMKTS:GNNSF) dropped 0.4% during trading on Monday . The stock traded as low as C$1.37 and last traded at C$1.37. Approximately 10,000 shares traded hands during trading, a decline of 83% from the average daily volume of 60,468 shares. The stock had previously closed at C$1.38.

Genscript Biotech Price Performance

The stock’s 50 day simple moving average is C$1.42 and its 200-day simple moving average is C$1.39.

Genscript Biotech Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.